Braidwell LP Day One Biopharmaceuticals, Inc. Transaction History
Braidwell LP
- $3.53 Trillion
- Q3 2024
A detailed history of Braidwell LP transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Braidwell LP holds 4,873,853 shares of DAWN stock, worth $62.3 Million. This represents 1.92% of its overall portfolio holdings.
Number of Shares
4,873,853
Previous 3,035,904
60.54%
Holding current value
$62.3 Million
Previous $41.8 Billion
62.29%
% of portfolio
1.92%
Previous 1.31%
Shares
8 transactions
Others Institutions Holding DAWN
# of Institutions
178Shares Held
84MCall Options Held
144KPut Options Held
218K-
Ra Capital Management, L.P. Boston, MA7.87MShares$101 Million1.53% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$82.2 Million11.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$75.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$58 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.87MShares$49.5 Million0.02% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $940M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...